Variability of clinical target volume delineation for definitive radiotherapy in cervix cancer

Radiotherapy and Oncology

Volumn 117, Issue 3, 2015, Pages 542-547

  Eminowicz, Gemma ^a   McCormack, Mary ^a  

^a UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Cervical cancer radiotherapy; Inter observer variation; Radiotherapy delineation

Indexed keywords

ALGORITHM; AORTA BIFURCATION; ARTICLE; CANCER RADIOTHERAPY; CLINICAL TARGET VOLUME; FEMALE; GOLD STANDARD; HUMAN; ONCOLOGICAL PARAMETERS; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; TREATMENT RESPONSE; UTERINE CERVIX CANCER; OBSERVER VARIATION; PATHOLOGY; UTERINE CERVICAL NEOPLASMS;

FEMALE; HUMANS; OBSERVER VARIATION; UTERINE CERVICAL NEOPLASMS;

EID: 84951335120     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2015.10.007     Document Type: Article

References (25)

1. [1] Portelance, L., Chao, K.S.C., Grigsby, P.W., et al. Intensity-modulated radiation therapy (IMRT) reduces small bowel, rectum, and bladder doses in patients with cervical cancer receiving pelvic and para-aortic irradiation. Int J Radiat Oncol Biol Phys 51 (2001), 261–266.
2. [2] Forrest, J., Presutti, J., Davidson, M., et al. A dosimetric planning study comparing intensity-modulated radiotherapy with four-field conformal pelvic radiotherapy for the definitive treatment of cervical carcinoma. Clin Oncol 24 (2012), e63–e70.
3. [3] Mundt, A., Roeske, J.C., Lujan, A.E., et al. Initial clinical experience with intensity-modulated whole-pelvis radiation therapy in women with gynecologic malignancies. Gynecol Oncol 82 (2001), 456–463.
4. [4] Salama, J.K., Roeske, J.C., Mehta, N., Mundt, A., Intensity-modulated radiation therapy in gynecologic malignancies. Curr Treat Options Oncol 5 (2004), 97–108.
5. [5] Gwynne, S., Spezi, E., Staffurth, J., et al. Inter-observer variation in outlining of pre-trial test case in the SCOPE1 Trial: a United Kingdom definitive chemoradiotherapy trial for esophageal cancer. Int J Radiat Oncol Biol Phys 81 (2011), S67–S68.
6. [6] Cazzaniga, L.F., Marinoni, M.A., Bossi, A., et al. Interphysician variability in defining the planning target volume in the irradiation of prostate and seminal vesicles. Radiother Oncol 47 (1998), 293–296.
7. [7] Valley, J., Bernier, J., Tercier, P.A., et al. Quality assurance of the EORTC radiotherapy trial 22931 for head and neck carcinomas: the dummy run. Radiother Oncol 47 (1998), 37–44.
8. [8] Meijer, G.J., Rasch, C., Remeijer, P., Lebesque, J.V., Three-dimensional analysis of delineation errors, setup errors, and organ motion during radiotherapy of bladder cancer. Int J Radiat Oncol Biol Phys 55 (2003), 1277–1287.
9. [9] Li, X.A., Tai, A., Arthur, D.W., et al. Variability of target and normal structure delineation for breast cancer radiotherapy: an RTOG Multi-Institutional and Multiobserver Study. Int J Radiat Oncol Biol Phys 73 (2009), 944–951.
10. [10] Vorwerk, H., Beckmann, G., Bremer, M., et al. The delineation of target volumes for radiotherapy of lung cancer patients. Radiother Oncol 91 (2009), 455–460.
11. [11] Petric, P., Dimopoulos, J., Kirisits, C., et al. Inter- and intraobserver variation in HR-CTV contouring: intercomparison of transverse and paratransverse image orientation in 3D-MRI assisted cervix cancer brachytherapy. Radiother Oncol 89 (2008 Nov), 164–171.
12. [12] Dimopoulos, J.C., De Vos, V., Berger, D., et al. Inter-observer comparison of target delineation for MRI-assisted cervical cancer brachytherapy: application of the GYN GEC-ESTRO recommendations. Radiother Oncol 91 (2009 May), 166–172.
13. [13] Weiss, E., Richter, S., Krauss, T., et al. Conformal radiotherapy planning of cervix carcinoma: differences in the delineation of the clinical target volume. Radiother Oncol 67 (2003), 87–95.
14. [14] Wu, D.H., Mayr, N., Karatas, Y., Interobserver variation in cervical cancer tumor delineation for image-based radiotherapy planning among and within different specialties. J App Clin Med Phys, 6, 2005.
15. [15] Warfield, S.K., Zou, K.H., Wells, W.M., Simultaneous truth and performance level estimation (STAPLE): an algorithm for the validation of image segmentation. IEEE Trans Med Imaging 23 (2004), 903–921.
16. [16] Deasy, J.O., Blanco, A.I., Clark, V.H., CERR: a computational environment for radiotherapy research. Med Phys 30 (2003), 979–985.
17. [17] Jena, R., Kirkby, N.F., Burton, K.E., et al. A novel algorithm for the morphometric assessment of radiotherapy treatment planning volumes. Br J Radiol 83 (2010), 44–51.
18. [18] Peterson, R.P., Truong, P.T., Kader, H.A., et al. Target volume delineation for partial breast radiotherapy planning: clinical characteristics associated with low interobserver concordance. Int J Radiat Oncol Biol Phys 69 (2007), 41–48.
19. [19] Gwynne, S., Spezi, E., Sebag-Montefiore, D., et al. Improving radiotherapy quality assurance in clinical trials: assessment of target volume delineation of the pre-accrual benchmark case. Br J Radiol, 1024, 2013, 20120398.
20. [20] Taylor, A., Rockall, A.G., Powell, M.E., An atlas of the pelvic lymph node regions to aid radiotherapy target volume definition. Clin Oncol 19 (2007 Sep), 542–550.
21. [21] Toita, T., Ohno, T., Kaneyasu, Y., et al. A consensus-based guideline defining the clinical target volume for pelvic lymph nodes in external beam radiotherapy for uterine cervical cancer. Jpn J Clin Oncol 40 (2010 May), 456–463.
22. [22] Small, W. Jr., Mell, L.K., Anderson, P., et al. Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy in postoperative treatment of endometrial and cervical cancer. Int J Radiat Oncol Biol Phys 71 (2008 Jun 1), 428–434.
23. [23] Taylor, A., Rockall, A.G., Reznek, R.H., Powell, M.E., Mapping pelvic lymph nodes: guidelines for delineation in intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 63 (2005), 1604–1612.
24. [24] Mitchell, D.M., Perry, L., Smith, S., et al. Assessing the effect of a contouring protocol on postprostatectomy radiotherapy clinical target volumes and interphysician variation. Int J Radiat Oncol Biol Phys 75 (2009 Nov 15), 990–993.
25. [25] Lim, K., Small, W. Jr., Portelance, L., et al. Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy for the definitive treatment of cervix cancer. Int J Radiat Oncol Biol Phys 79 (2011 Feb 1), 348–355.